Vaccentis is planning to enter a collaboration with the Institute Krems Bioanalytics to optimize CMC aspects of VCC-001.
The profound experience of the Bioanalytic institute will further support the standardization of the individualized VCC-001 treatment. A successful workshop with the Bioanalytics team was held on June 21st 2023.
